Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sava Raicevic"'
Autor:
Milena Todorovic Balint, Jelena Jelicic, Biljana Mihaljevic, Jelena Kostic, Bojana Stanic, Bela Balint, Nadja Pejanovic, Bojana Lucic, Natasa Tosic, Irena Marjanovic, Maja Stojiljkovic, Teodora Karan-Djurasevic, Ognjen Perisic, Goran Rakocevic, Milos Popovic, Sava Raicevic, Jelena Bila, Darko Antic, Bosko Andjelic, Sonja Pavlovic
Publikováno v:
International Journal of Molecular Sciences, Vol 17, Iss 5, p 683 (2016)
The existence of a potential primary central nervous system lymphoma-specific genomic signature that differs from the systemic form of diffuse large B cell lymphoma (DLBCL) has been suggested, but is still controversial. We investigated 19 patients w
Externí odkaz:
https://doaj.org/article/9b6cb9662d8c400290e0520dfe0658d5
Autor:
Bosko Andjelic, Vladislava Djurasinovic, Rosanda Ilić, Sava Raicevic, Milena Todorovic Balint, Jelena Jelicic, Darko Antic, Bela Balint, Dejana Stanisavljevic, Jelena Bila, Vojin Vukovic, Biljana Mihaljevic, Aleksandra Sretenovic
Publikováno v:
British journal of neurosurgery. 30(1)
The aim of the study was to evaluate retrospectively clinical course of 27 patients with primary central nervous system lymphoma (PCNSL) diagnosed and treated by different surgical approaches. Initial therapy-diagnostic approach included surgery with
Autor:
Bela Balint, Natasa Tosic, Maja Stojiljkovic, Jelena Bila, Irena Marjanovic, Bosko Andjelic, Ognjen Perišić, Darko Antic, Sonja Pavlovic, Jelena Jelicic, Milena Todorovic Balint, Sava Raicevic, Jelena Kostic, Bojana Lucic, Bojana Stanic, Biljana Mihaljevic, Goran Rakocevic, Milos Popovic, Teodora Karan-Djurasevic, Nadja Pejanovic
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 17, Iss 5, p 683 (2016)
International Journal of Molecular Sciences; Volume 17; Issue 5; Pages: 683
International Journal of Molecular Sciences, Vol 17, Iss 5, p 683 (2016)
International Journal of Molecular Sciences; Volume 17; Issue 5; Pages: 683
The existence of a potential primary central nervous system lymphoma-specific genomic signature that differs from the systemic form of diffuse large B cell lymphoma (DLBCL) has been suggested, but is still controversial. We investigated 19 patients w